13-21689811-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002010.3(FGF9):c.381+8666T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.278 in 152,142 control chromosomes in the GnomAD database, including 7,144 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.28 ( 7144 hom., cov: 32)
Consequence
FGF9
NM_002010.3 intron
NM_002010.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.564
Publications
2 publications found
Genes affected
FGF9 (HGNC:3687): (fibroblast growth factor 9) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This protein was isolated as a secreted factor that exhibits a growth-stimulating effect on cultured glial cells. In nervous system, this protein is produced mainly by neurons and may be important for glial cell development. Expression of the mouse homolog of this gene was found to be dependent on Sonic hedgehog (Shh) signaling. Mice lacking the homolog gene displayed a male-to-female sex reversal phenotype, which suggested a role in testicular embryogenesis. [provided by RefSeq, Jul 2008]
FGF9 Gene-Disease associations (from GenCC):
- multiple synostoses syndrome 3Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- multiple synostoses syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.409 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FGF9 | NM_002010.3 | c.381+8666T>C | intron_variant | Intron 2 of 2 | ENST00000382353.6 | NP_002001.1 | ||
| FGF9 | XM_011534996.3 | c.231+8666T>C | intron_variant | Intron 2 of 2 | XP_011533298.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FGF9 | ENST00000382353.6 | c.381+8666T>C | intron_variant | Intron 2 of 2 | 1 | NM_002010.3 | ENSP00000371790.5 | |||
| FGF9 | ENST00000461657.1 | n.315+8666T>C | intron_variant | Intron 2 of 2 | 5 | |||||
| FGF9 | ENST00000478546.1 | n.141+8558T>C | intron_variant | Intron 1 of 1 | 2 |
Frequencies
GnomAD3 genomes AF: 0.278 AC: 42263AN: 152022Hom.: 7148 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
42263
AN:
152022
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.278 AC: 42269AN: 152142Hom.: 7144 Cov.: 32 AF XY: 0.282 AC XY: 20989AN XY: 74376 show subpopulations
GnomAD4 genome
AF:
AC:
42269
AN:
152142
Hom.:
Cov.:
32
AF XY:
AC XY:
20989
AN XY:
74376
show subpopulations
African (AFR)
AF:
AC:
3267
AN:
41524
American (AMR)
AF:
AC:
5110
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
1298
AN:
3470
East Asian (EAS)
AF:
AC:
2186
AN:
5160
South Asian (SAS)
AF:
AC:
1653
AN:
4812
European-Finnish (FIN)
AF:
AC:
4281
AN:
10592
Middle Eastern (MID)
AF:
AC:
95
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23555
AN:
67982
Other (OTH)
AF:
AC:
614
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1467
2934
4400
5867
7334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1285
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.